IT8048119A0 - Composti 6-aril pirimidinici per il trattamento e la prevenzione di in fezioni virali e per stimolare laproduzione di interferone - Google Patents

Composti 6-aril pirimidinici per il trattamento e la prevenzione di in fezioni virali e per stimolare laproduzione di interferone

Info

Publication number
IT8048119A0
IT8048119A0 IT8048119A IT4811980A IT8048119A0 IT 8048119 A0 IT8048119 A0 IT 8048119A0 IT 8048119 A IT8048119 A IT 8048119A IT 4811980 A IT4811980 A IT 4811980A IT 8048119 A0 IT8048119 A0 IT 8048119A0
Authority
IT
Italy
Prior art keywords
infetions
aril
interferon
stimulate
viral
Prior art date
Application number
IT8048119A
Other languages
English (en)
Other versions
IT1143012B (it
Inventor
Wendell Wierenga
Harvey Irving Skulnich
Dale Alan Stringfellow
Patricia Evelyn Fast
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of IT8048119A0 publication Critical patent/IT8048119A0/it
Application granted granted Critical
Publication of IT1143012B publication Critical patent/IT1143012B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT48119/80A 1979-03-19 1980-03-10 Composti 6-aril pirimidinici per il trattamento e la prevenzione di infezioni virali e per stimolare la produzione di interferone IT1143012B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2220579A 1979-03-19 1979-03-19
US7985079A 1979-09-28 1979-09-28

Publications (2)

Publication Number Publication Date
IT8048119A0 true IT8048119A0 (it) 1980-03-10
IT1143012B IT1143012B (it) 1986-10-22

Family

ID=26695670

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48119/80A IT1143012B (it) 1979-03-19 1980-03-10 Composti 6-aril pirimidinici per il trattamento e la prevenzione di infezioni virali e per stimolare la produzione di interferone

Country Status (7)

Country Link
JP (1) JPH0627070B2 (it)
CH (1) CH646958A5 (it)
DE (1) DE3008693A1 (it)
FR (1) FR2451918A1 (it)
GB (1) GB2048250B (it)
IT (1) IT1143012B (it)
NL (1) NL8001568A (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0111440A1 (en) * 1982-10-15 1984-06-20 Ciba-Geigy Ag 2-Aminopyrimidines, their production and use
US4795812A (en) * 1985-02-05 1989-01-03 The Upjohn Company 4-substituted-6-aryl-pyrimidine compounds
GB9012311D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
WO1998025596A2 (en) * 1996-12-12 1998-06-18 Pharmacia & Upjohn Company Use of a 6-aryl pyrimidine compound for treating multiple sclerosis
US6495558B1 (en) 1999-01-22 2002-12-17 Amgen Inc. Kinase inhibitors
EP1144390A2 (en) * 1999-01-22 2001-10-17 Amgen Inc., Kinase inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2688019A (en) * 1951-08-25 1954-08-31 Burroughs Wellcome Co 6-aryl-2,4-diamino pyrimidines and process of preparing same
US2723977A (en) * 1953-07-29 1955-11-15 Searle & Co 5, 6-disubstituted 2-amino-4-pyrimidols
US2723978A (en) * 1954-01-14 1955-11-15 Searle & Co 2-amino-5-alkenyl-6-phenyl-4-pyrimidols
US2710867A (en) * 1954-03-12 1955-06-14 Searle & Co New 2-amino-4-pyrimidol derivatives
US2748121A (en) * 1954-06-17 1956-05-29 Searle & Co 6-nitroaryl derivatives of 2-amino-4-pyrimidols
US2704285A (en) * 1954-06-17 1955-03-15 Searle & Co 2-amino-5-(lower alkyl)-6-substituted phenyl-4-pyrimidols
US3281420A (en) * 1966-01-27 1966-10-25 Searle & Co Carboxylic acid [2-(2-amino-4-azido-6-phenyl-5-pyrimidinyl)-1-methylethylidene] hydrazides and intermediate
US3412094A (en) * 1967-06-21 1968-11-19 Searle & Co 5-alkyl-2-amino-4-azido-6-phenylpyrimidines and congeners
US3932617A (en) * 1974-05-24 1976-01-13 The Upjohn Company Interferon induction

Also Published As

Publication number Publication date
JPH0627070B2 (ja) 1994-04-13
CH646958A5 (de) 1984-12-28
FR2451918B1 (it) 1984-01-06
NL8001568A (nl) 1980-09-23
GB2048250B (en) 1983-04-27
IT1143012B (it) 1986-10-22
GB2048250A (en) 1980-12-10
DE3008693A1 (de) 1980-10-02
JPH0517451A (ja) 1993-01-26
FR2451918A1 (fr) 1980-10-17

Similar Documents

Publication Publication Date Title
IT1234215B (it) Forma di dosaggio per il trattamento di malattie cardiovascolari
ZA761627B (en) Improvements in or relating to the treatment of arthritis
IT1113289B (it) Perfezionamento nei pannelli per la produzione di solette imbottite
ZA878877B (en) Treatment of diseases caused by viruses
IT1170561B (it) Elemento strutturale di mobile, in particolare di mobile per sedersi o sdraiarsi
IT1153294B (it) Composizione di antralina migliorata e suo uso nel trattamento di malattie della pelle
IT1057895B (it) Gonadotropina corionica umana parzialmente desalinizzata per indurre l'ouvulazione
ES535509A0 (es) Procedimiento para purificar interferon de humano
IT8048119A0 (it) Composti 6-aril pirimidinici per il trattamento e la prevenzione di in fezioni virali e per stimolare laproduzione di interferone
IT1173329B (it) Procedimento per la trasformazione quantitativa di teicoplanina a2 fattore 1 in teicoplanina a2 fattore 3
IT1188236B (it) Perfezionamenti apportati al trattamento di materiali in particelle
ZA77540B (en) Improvements in or relating to the treatment of glass
IT7967029A0 (it) Amminoderivati della pirazolo i 5 as triazina particolarmente utili in terapia e procedimento per la loropreparazione
ZA786208B (en) Improvements in or relating to the manufacture of cementitious products
IT1163931B (it) Composizione e metodo per impedire la formazione di incrostazioni
IT1123756B (it) Procedimento per la fabbricazione continua di pannelli,in particolare di pannelli di masonite
IT1124820B (it) Perfezionamento nelle camere per il trattamento di pezzi
IT1221010B (it) Impiego di chinoloni nel trattamento di malattie cardiache
IT8149992A0 (it) Procedimento per la produzione del fattore di attivita' di stimolo del la moltiplicazione cellulare nell'uomo
IT1159815B (it) Composizione medicinale per il trattamento di certe neurovirosi
GB8522962D0 (en) Treatment of viral diseases in plants
IT8467607A1 (it) Composizione farmaceutica per ritardare l'invecchiamento nell'uomo.
BR8206826A (pt) Conjunto de pratos para servir
EG12095A (en) Improvements in or relating to the thermal treatment of glass
ZA792487B (en) Process for the preparation of 2-isopropylamino pyrimidine

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19990331